Bloomberg Launches Screened Choice Equity Indices for Custom Investment Strategies

Bloomberg today announced the launch of the Bloomberg Screened Choice Indices, a comprehensive and customizable suite of market cap-weighted equity benchmarks designed to help investors integrate their choice of values-based exclusions into their portfolios. Users can choose to use the new benchmarks or fully customize the screening to their individual preferences. https://mma.prnewswire.com/media/649927/Bloomberg_Black_Logo.jpg “The launch of […]

Resolution Therapeutics announces first patient dosed in Phase I/II EMERALD study of RTX001 for the treatment of end-stage liver disease

— RTX001 is the first engineered Regenerative Macrophage Therapy (RMT) to be evaluated in humans with advanced liver fibrosis — First patient has successfully cleared safety period with no serious adverse events — Enrolment is now open for the study, with initial data readout expected in 2026 Resolution Therapeutics (“Resolution” or “Company”), a clinical-stage biopharmaceutical

Dundee Precious Metals Completes Acquisition of Adriatic Metals and Confirms Name Change and ASX Listing

(TSX:DPM), TORONTO, Sept. 03, 2025 (GLOBE NEWSWIRE) — Dundee Precious Metals Inc. (TSX:DPM) (“DPM”) is pleased to announce the completion of its previously announced acquisition (the “Acquisition”) of the entire issued, and to be issued, ordinary share capital of Adriatic Metals Plc (“Adriatic Metals”), by means of a court-sanctioned scheme of arrangement (the “Scheme”) under

Dundee Precious Metals Completes Acquisition of Adriatic Metals and Confirms Name Change and ASX Listing

Dundee Precious Metals Completes Acquisition of Adriatic Metals and Confirms Name Change and ASX Listing GlobeNewswire September 03, 2025 TORONTO, Sept. 03, 2025 (GLOBE NEWSWIRE) — Dundee Precious Metals Inc. (TSX:DPM) (“DPM”) is pleased to announce the completion of its previously announced acquisition (the “Acquisition”) of the entire issued, and to be issued, ordinary share

Physitrack PLC Adjusts its Financial Calendar – Earlier Publication of Q3 2025 Interim Report

LONDON, GB / ACCESS Newswire / September 3, 2025 / Physitrack PLC (STO:PTRK) – Physitrack PLC has adjusted its previously communicated financial calendar for 2025. The date for publication of the Q3 2025 interim report has been changed from 31 October 2025 to 21 October 2025. Updated financial calendar21 October 2025 – Interim report Q3

REPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit againstReplimune Group, Inc. (“Replimune” or “the Company”) (NASDAQ: REPL)forviolations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Investors who purchased the Company's

NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit againstNovo Nordisk A/S (“Novo Nordisk” or “the Company”) (NYSE: NVO)forviolations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. https://mma.prnewswire.com/media/1396534/Schall_Firm_Logo.jpg Investors who purchased the

KLC LAWSUIT ALERT: Levi & Korsinsky Notifies KinderCare Learning Companies, Inc. Investors – Lead Plaintiff Deadline October 14, 2025

NEW YORK, NY / ACCESS Newswire / September 3, 2025 / If you suffered a loss on your KinderCare Learning Companies, Inc. (NYSE:KLC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/kindercare-learning-companies-inc-lawsuit-submission-form?prid=164904&wire=1&utm_campaign=7 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

Inoria, a CallTower Company, to Sponsor Genesys Xperience 2025

SALT LAKE CITY, UT, ROCHESTER, NY, MONTREAL, LONDON, Sept. 03, 2025 (GLOBE NEWSWIRE) — Inoria, a CallTower company, announced its participation as a Silver sponsor at Xperience 2025 hosted by Genesys(R), a global cloud leader in AI-Powered Experience Orchestration. Xperience, the CX event of the year, will take place Sept. 8-10 at the Gaylord Opryland

Inoria, a CallTower Company, to Sponsor Genesys Xperience 2025

Inoria, a CallTower Company, to Sponsor Genesys Xperience 2025 Xperience participation reinforces Inoria's dedication to transforming contact center as a service through cutting-edge solutions GlobeNewswire September 03, 2025 SALT LAKE CITY, UT, ROCHESTER, NY, MONTREAL, LONDON, Sept. 03, 2025 (GLOBE NEWSWIRE) — Inoria, a CallTower company, announced its participation as a Silver sponsor at Xperience

Scroll to Top